Half-year report · Q2
7133.TEDINET S100UP3P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥449m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥717m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥6.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥5.0bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥889m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥688m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥889m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥688m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥707m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥539m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥41.03 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.62 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.26 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 19
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥296m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥277m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥338m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥134m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥749m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥745m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 331
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | CurrentYTDDuration | 435136000 | JPY |
| Income taxes | CurrentYTDDuration | 143807000 | JPY |
| Profit loss | CurrentYTDDuration | 291328000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 291328000 | JPY |
| Profit loss | CurrentYTDDuration | 291328000 | JPY |
| Other comprehensive income | CurrentYTDDuration | － | JPY |
| Comprehensive income | CurrentYTDDuration | 291328000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 291328000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Income before income taxes | CurrentYTDDuration | 435136000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 128899000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 4300000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -43788000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -1751000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 17904000 | JPY |
| Subsidy income ope cf | CurrentYTDDuration | -2689000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -159241000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -56847000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 92699000 | JPY |
| Other net ope cf | CurrentYTDDuration | -56126000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 358496000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 3432000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -18009000 | JPY |
| Proceeds from subsidy ope cf | CurrentYTDDuration | 4163000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -160476000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 187606000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -85150000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -48651000 | JPY |
| Purchase of long term prepaid expenses inv cf | CurrentYTDDuration | -875000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -54023000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 618000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -188082000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 250000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 100000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -132207000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -16844000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 412000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 201360000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 200885000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 688010000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 888896000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 215490000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 12285000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | 3416139000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E37198-000KirariPrimeReportableSegmentsMember | 543936000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E37198-000PrimaryCareHomeReportableSegmentsMember | 758892000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 4718967000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 420000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4719387000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |